The Solstice SRS Immobilization System has received FDA 510K clearance and CE Mark.  The news was announced today by CIVCO Radiotherapy.

The product will be available for shipment following its display at the American Society for Radiation Oncology (ASTRO) Meeting taking place October 21-24, 2018 in San Antonio, Texas.

The Solstice SRS Immobilization System offers unique corrective pitch capability and positioning flexibility. It features customizable components that create a comfortable head and neck immobilization system for precise radiotherapy treatments to improve patient outcomes. The system is comprised of a carbon fiber head support, customizable cushion and dedicated thermoplastic mask designed for secure and simple attachment.

“The Solstice SRS Immobilization System is the only midline thermoplastic mask system on the market with variable pitch capability, increasing setup options in CT simulation and allowing positioning flexibility during treatment,” commented John Steffen, Director of Product Management at CIVCO. “We are excited that clearance in the U.S. and EU CE marking opens opportunities for us to provide this unique solution to radiotherapy clinics to help improve patient outcomes.”